121 related articles for article (PubMed ID: 16403279)
1. [Induction of immune tolerance for allogenic recipient mice by non-myeloablative bone marrow transplantation].
Chen BA; Bi YZ; Ding JH; Zhang Y; Gao C; Sun YY; Zhao G; Wang J; Cheng J; Sun XM; Schmitt M; Döhner H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1054-7. PubMed ID: 16403279
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D
J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
[TBL] [Abstract][Full Text] [Related]
3. [Induction of skin allograft tolerance in mice by using anti-alphabeta T cell receptor and anti-CD80 monoclonal antibodies combined with bone marrow transfusion].
Hao J; Liu JW; Gao X; Yuan GH; Xie SS
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 38(4):365-9. PubMed ID: 16892139
[TBL] [Abstract][Full Text] [Related]
4. [Study on the improved effect of anti-TCR alpha beta monoclonal antibody on the induction of transplantation tolerance to the allogeneic skin graft in mice and its mechanisms].
Hao J; Liu J; Xie S
Zhonghua Yi Xue Za Zhi; 2001 May; 81(10):593-6. PubMed ID: 11798930
[TBL] [Abstract][Full Text] [Related]
5. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic intra-BM-BMT plus adult thymus transplantation from same donor has benefits for long-term survival even after sublethal irradiation or low-dose BM cell injection.
Nishida T; Hosaka N; Takaki T; Miyake T; Cui W; Inaba M; Kinoshita H; Matsuda T; Ikehara S
Bone Marrow Transplant; 2009 Jun; 43(11):829-37. PubMed ID: 19079314
[TBL] [Abstract][Full Text] [Related]
7. [Induction of skin immune tolerance of mouse to rat xenogeneic transplantation].
Song X; Huang H; Hao J; Xie S
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Dec; 22(6):508-10. PubMed ID: 12903391
[TBL] [Abstract][Full Text] [Related]
8. Long-term donor-specific tolerance in rat cardiac allografts by intrabone marrow injection of donor bone marrow cells.
Guo K; Inaba M; Li M; An J; Cui W; Song C; Wang J; Cui Y; Sakaguchi Y; Tsuda M; Omae M; Ando Y; Li Q; Wang X; Feng W; Ikehara S
Transplantation; 2008 Jan; 85(1):93-101. PubMed ID: 18192918
[TBL] [Abstract][Full Text] [Related]
9. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen.
Tomita Y; Khan A; Sykes M
J Immunol; 1994 Aug; 153(3):1087-98. PubMed ID: 8027542
[TBL] [Abstract][Full Text] [Related]
10. A new method for tolerance induction: busulfan administration followed by intravenous injection of neuraminidase-treated donor bone marrow.
Nagahama T; Sugiura K; Lee S; Morita H; Adachi Y; Kwon AH; Kamiyama Y; Ikehara S
Stem Cells; 2001; 19(5):425-35. PubMed ID: 11553851
[TBL] [Abstract][Full Text] [Related]
11. The CD28 peptidemimic can induce mixed chimerism and prolong the survival of cardiac allografts.
Chen J; He Q; Xu H; Su L; Zhang J; Xiong S
Transpl Immunol; 2004 Dec; 13(4):283-8. PubMed ID: 15589741
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic efficacy of polyclonal tregs does not require rapamycin in a low-dose irradiation bone marrow transplantation model.
Pilat N; Klaus C; Gattringer M; Jaeckel E; Wrba F; Golshayan D; Baranyi U; Wekerle T
Transplantation; 2011 Aug; 92(3):280-8. PubMed ID: 21697774
[TBL] [Abstract][Full Text] [Related]
13. A more persistent tolerance to islet allografts through bone marrow transplantation in minimal nonmyeloablative conditioning therapy.
Lee BW; Lee JI; Oh SH; Ahn YR; Chae HY; Lee MS; Lee MK; Kim KW
Transplant Proc; 2005 Jun; 37(5):2266-9. PubMed ID: 15964395
[TBL] [Abstract][Full Text] [Related]
14. Administration of granulocyte colony-stimulating factor to recipients followed by intra-bone marrow-bone marrow transplantation accelerates acceptance of allogeneic bone marrow cells in mice.
Suzuki Y; Adachi Y; Zhang Y; Minamino K; Iwasaki M; Mukaide H; Shi M; Nakano K; Koike Y; Wang J; Koike-Kiriyama N; Shigematsu A; Yanai S; Ikehara S
Immunobiology; 2008; 213(5):427-35. PubMed ID: 18472051
[TBL] [Abstract][Full Text] [Related]
15. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
Zhao J; Zhao XY; Huang XJ
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2497-502. PubMed ID: 16321278
[TBL] [Abstract][Full Text] [Related]
16. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.
Colson YL; Li H; Boggs SS; Patrene KD; Johnson PC; Ildstad ST
J Immunol; 1996 Oct; 157(7):2820-9. PubMed ID: 8816385
[TBL] [Abstract][Full Text] [Related]
17. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
Du B; Li DP; Xu KL; Pan XY
Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs.
Tillson M; Niemeyer GP; Welch JA; Brawner W; Swaim SF; Rynders P; Lenz SD; Dean B; Lothrop CD
Exp Hematol; 2006 Dec; 34(12):1759-70. PubMed ID: 17157174
[TBL] [Abstract][Full Text] [Related]
19. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
[TBL] [Abstract][Full Text] [Related]
20. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
